• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Voyager Acquisition Corp

    5/14/25 12:42:29 PM ET
    $VACH
    Get the next $VACH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Voyager Acquisition Corp.

    (Name of Issuer)


    Class A ordinary shares, par value $0.0001 per share

    (Title of Class of Securities)


    G93A7H104

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    G93A7H104


    1Names of Reporting Persons

    AQR Capital Management, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,418,939.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,418,939.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,418,939.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.61 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    G93A7H104


    1Names of Reporting Persons

    AQR Capital Management Holdings, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,418,939.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,418,939.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,418,939.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.61 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    G93A7H104


    1Names of Reporting Persons

    AQR Arbitrage, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,418,939.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,418,939.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,418,939.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.61 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Voyager Acquisition Corp.
    (b)Address of issuer's principal executive offices:

    C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON, TEXAS 77002
    Item 2. 
    (a)Name of person filing:

    AQR Capital Management, LLC AQR Capital Management Holdings, LLC AQR Arbitrage, LLC
    (b)Address or principal business office or, if none, residence:

    ONE GREENWICH PLAZA SUITE 130 Greenwich, Connecticut 06830
    (c)Citizenship:

    AQR Capital Management, LLC - UNITED STATES AQR Capital Management Holdings, LLC - UNITED STATES AQR Arbitrage, LLC - UNITED STATES
    (d)Title of class of securities:

    Class A ordinary shares, par value $0.0001 per share
    (e)CUSIP No.:

    G93A7H104
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    1,418,939
    (b)Percent of class:

    5.61  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0 AQR Arbitrage, LLC - 0

     (ii) Shared power to vote or to direct the vote:

    AQR Capital Management, LLC - 1,418,939 AQR Capital Management Holdings, LLC - 1,418,939 AQR Arbitrage, LLC - 1,418,939

     (iii) Sole power to dispose or to direct the disposition of:

    AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0 AQR Arbitrage, LLC - 0

     (iv) Shared power to dispose or to direct the disposition of:

    AQR Capital Management, LLC - 1,418,939 AQR Capital Management Holdings, LLC - 1,418,939 AQR Arbitrage, LLC - 1,418,939

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Item 2(a) above.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    AQR Capital Management, LLC
     
    Signature:Henry Parkin
    Name/Title:Authorized Signatory
    Date:05/14/2025
     
    AQR Capital Management Holdings, LLC
     
    Signature:Henry Parkin
    Name/Title:Authorized Signatory
    Date:05/14/2025
     
    AQR Arbitrage, LLC
     
    Signature:Henry Parkin
    Name/Title:Authorized Signatory
    Date:05/14/2025
    Exhibit Information

    AQR Capital Management Holdings, LLC, AQR Capital Management, LLC, and AQR Arbitrage, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC. AQR Arbitrage, LLC is deemed to be controlled by AQR Capital Management, LLC.

    Get the next $VACH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VACH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VACH
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Voyager Acquisition Corp

    SCHEDULE 13G - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    2/10/26 5:58:28 PM ET
    $VACH

    SEC Form 425 filed by Voyager Acquisition Corp

    425 - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    2/3/26 7:05:29 AM ET
    $VACH

    Voyager Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Voyager Acquisition Corp./Cayman Islands (0002006815) (Filer)

    2/3/26 7:04:57 AM ET
    $VACH

    $VACH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology

    ZURICH, SWITZERLAND, and MARTINSRIED/MUNICH, GERMANY – September 30, 2025 -- VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")), and Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced a strategic research collaboration to develop next-generation antibody oligonucleotide conjugates (AOCs). The combination of both technology platforms aims to unlock novel targeted therapies for the treatment of autoimmune and chronic immune diseases AOCs combine the specificity of monoclonal anti

    9/30/25 8:00:00 AM ET
    $VACH

    VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

    ZURICH, SWITZERLAND, July 17, 2025 -- VERAXA Biotech AG ("VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp.,  a Cayman Islands exempted company and special purpose acquisition company targeting the healthcare sector (NASDAQ:VACH, "Voyager" or the "SPAC")), announced today the filing of a registration statement on Form F-4 (the "Registration Statement"), which includes a preliminary proxy statement, with the U.S. Securities and Exchange Commission ("SEC") in regards to the proposed Business Combination Agreement announced April 23, 2025. "We are excited to share this pivotal milestone in VERAXA's journey toward becoming a publi

    7/17/25 1:00:00 AM ET
    $VACH

    VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

    ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")), announced today it will be attending the upcoming ASCO Annual Meeting and BIO International Convention. At the conferences, Christoph Antz, CEO, and additional members of the VERAXA leadership team will be meeting with potential partners and investors, showcasing the Company's novel Bi-targeted Tumor-Associated Cytotoxicity (BiTAC) platform, and sharing the Company's growth plans as it prepares to list on the NASDAQ later this year. VERAXA is leveraging its proprietary BiTAC p

    5/29/25 10:34:13 AM ET
    $VACH

    $VACH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Voyager Acquisition Corp

    SC 13G - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    11/14/24 5:32:56 PM ET
    $VACH

    SEC Form SC 13G filed by Voyager Acquisition Corp

    SC 13G - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    11/14/24 1:17:46 PM ET
    $VACH

    Amendment: SEC Form SC 13G/A filed by Voyager Acquisition Corp

    SC 13G/A - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    11/6/24 3:00:45 PM ET
    $VACH